Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and ...

A short film that premiered earlier this month tracks the journeys of three people who discovered a renewed commitment to ...

Chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL) are types of blood cancer. They develop in types of white blood cells called B cells or T cells, or the precursors to these cells.

The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies.

Experts recently set out to determine whether distinct subpopulations of clonal cells with different proliferative potential exist within the same individual with CLL. The study used deuterium-labeled ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, will ...

Nitin Jain, MD: Samantha came to the MD Anderson Cancer Center with an abnormal white blood cell count on day one. Most of the time for CLL [chronic lymphocytic leukemia], patients present in a way ...

Patients with relapsed or refractory chronic lymphocytic leukemia (R/R CLL) had similar results when they continued on ibrutinib or stopped and started ibrutinib plus venetoclax based on minimal ...

Insights from ASH 2025, including anticipated presentations, key takeaways, and how new research in chronic lymphocytic ...

Researchers at the University of Eastern Finland and their international collaborators have identified key developmental and ...

Chronic lymphocytic leukemia (CLL) is a type of blood cancer that affects white blood cells called lymphocytes. There are many types of leukemia, and CLL is a common type in adults. This type of ...

Patients with chronic lymphocytic leukemia (CLL) had significantly lower monocyte-to-lymphocyte ratio values compared with healthy controls. A comparison of the second-generation Bruton tyrosine ...